Last reviewed · How we verify
NCT04550559
Rate of Spontaneous Stone Passage as Assessed Using Urinary Ultrasonography and Direct Urinary System Radiography
NA trial testing Endoscopic ureterolitotripsy in Ureteral Calculi in 149 participants. Completed in 31 March 2020.
31 March 2020
Quick facts
| Lead sponsor | Avrasya University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 149 |
| Start date | 1 February 2018 |
| Primary completion | 31 March 2020 |
| Estimated completion | 31 March 2020 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Endoscopic ureterolitotripsy
Conditions studied
- Ureteral Calculi — all drugs for Ureteral Calculi →
- Masturbation — all drugs for Masturbation →
Sponsor
Avrasya University
Who can join
Adults 18 to 75, male only, with Ureteral Calculi or Masturbation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate the effect of masturbation on the spontaneous expulsion of distal ureteral stones 5-10 mm in size.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04550559
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Ureteral Calculi
Currently open trials in the same condition.
- NCT03873259 — Intraoperative Assessment of of Burst Wave Lithotripsy (BWL) · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04550559 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Avrasya University
- Last refreshed: 16 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04550559.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing